한국미생물·생명공학회지 (Microbiology and Biotechnology Letters)

  • 제31권1호
  • /
  • Pages.1-12
  • /
  • 2003
  • /
  • 1598-642X(pISSN)
  • /
  • 2234-7305(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지

Myxobacteria의 생리활성 물질

Bioactive Substances from Myxobacteria.

  • 김용석 (일양약품 중앙연구소 생물공학팀) ;
  • 배우철 (일양약품 중앙연구소 생물공학팀) ;
  • 백성진 (일양약품 중앙연구소 생물공학팀)
  • 발행 : 2003.03.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Myxobacteria는 토양세균으로 활주하여 이동하며, 복잡한 생활사를 갖고 있다. 25년 이상의 연구결과 myxobacteria는 많은 생리활성물질을 생산한다는 사실이 밝혀졌으며, 지금까지 약 80종의 신규물질과 그들의 변이체가 450종이 확인되었다. 이들 물질들은 독특한 기작을 갖고 있는 것들이 많으며, 그 중에는 26종의 electron transport 저해제, 5종의 nucleic acid polymerase 저해제, 10종의 cytoskeleton에 작용하는 물질, 1종의 진균 acetyl-CoA carboxylase 저해제이다. 그러나 아직까지 myxobacteria 유래물질들을 대량으로 생산하기 위한 공정이 완벽하게 성립되어 있지 않고, 이들 물질들을 이용한 제품이 시판되는 상황은 아니지만, 머지않아 myxobacteria가 생산하는 생리활성물질들을 항균, 항암과 같은 질병치료 및 기타 다양한 분야에서 이용 가능하게 될 것이다.

Myxobacteria are soil bacteria that move by gliding and have a complicated life cycle. In the research over the 25 years the myxobacteria have been shown to be a rich source of potentially useful bioactive substances. So far about 80 different basic compounds and 450 structural variants have been characterized. It is remarkable that myxobacteria produce the substance has special mechanisms. 26 new electron transport inhibitors,5 inhibitors of nucleic acid polymerases, 10 substances that act on the cytoskeleton, and 1 inhibitor of fungal acetyl-CoA carboxylase have been found. Presently, large-scale technical process was not fully established. But one of the compounds from myxobacteria is able to pass the many thresholds, which are on the road to application.

키워드

참고문헌

  1. Yakhak Hoeji v.46 Isolation and properties of cytotoxic antibiotics from Myxococcus stipitauts JW150 Ahn, J. W.;C. O. Lee
  2. J. Nat. Prod v.62 KR025, a new cytotoxic compound from Myxococcus fulvus Ahn,J.W.;S.H.Woo;C.O.Lee;K.Y.Cho;B.S.Kim https://doi.org/10.1021/np9804233
  3. J. Bacteriol v.132 Intracellular, periodic structures in the gliding bacterium Myxococcus xanthus Burchard,A.C.;P.R.Burchard;J.A.Kloetzel
  4. Microbios v.73 Antifungal activity of Myxococcus species i production, physicochemical and biological properties of antibiotics from Myxococcus fulvus S110 (Myxobacterales) Daoud,N.N.;H.A.Foster
  5. FEMS Microbiol. Rev. v.24 Biology and global distribution of myxobacteria in soils Dawid, W. https://doi.org/10.1111/j.1574-6976.2000.tb00548.x
  6. J. Bacteriol. v.164 Distribution of multicopy single stranded DNA among myxobacteria and related species Dhundale, A. R.;T. Furuichi;S.Inouye;M. Inouye.
  7. Microbiol. Rev. v.60 Recent advances in the social and developmental biology of the myxobacteria Dworkin,M.
  8. J. Antibiot. v.54 Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium.2.Isolation and structural elucidation Fudou, R. T.;Lizuka, S. Sato;T. Ando;N. Shimba;S. Yamanaka.
  9. J. Antibiot v.48 Ratjadon:a new antifungal compound from Sorangium cellulosum (myxobacteria) production,physio-chemical and iological properties Gerth,K.;D.Schummer;G.Hofle;H.Irschik;H.Reichen-bach https://doi.org/10.7164/antibiotics.48.973
  10. J. Antibiot. v.33 Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and bilogical properties Gerth, K.;H. Irschik;H. Reichenbach;W. Trowitzsch. https://doi.org/10.7164/antibiotics.33.1474
  11. J. Antibiot v.49 Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Productio,physico-chemical and biological properties Gerth,K.;N.Bedorf;G.Hofle;H.Irschik;H.Reichen-bach https://doi.org/10.7164/antibiotics.49.560
  12. J. Antibiot. v.47 The soraphens: a family of novel antifungal sompounds form Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties Gerth, K;N. Bedofr;H. Irschik;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.47.23
  13. J. Antibiot v.49 The jerangolids: A family of new antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties of Jerangolid A. Gerth,K.;P.Washausen;G.Hofle;H.Irschik;H.Reichen-bach https://doi.org/10.7164/antibiotics.49.71
  14. J. Antibiot. v.36 The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action Gerth, K.;R. Jansen;G. Reifenstahl;G. Hofle;H. Irschik;B. Kunze;H. Reichenbach;G.Thierbach https://doi.org/10.7164/antibiotics.36.1150
  15. J. Antibiot v.35 Pyrrolnitrin from Myxococcus fulvus (Myxobacterales) Gerth,K.;W.Trowitzsch;V.Wray;G.Hofle;H.Irschik;H.Reichenbach https://doi.org/10.7164/antibiotics.35.1101
  16. J. Antibiot. v.35 The myxovirescins, a family of antibiotics from Myxococcus virescens(Myxobacterales) Gerth, K.;H. Irschik;H. Reichenbach;W. Trowitzsch. https://doi.org/10.7164/antibiotics.35.1454
  17. Arch. Microbiol v.116 Myxobacterial slime and proteolytic activity Gnosspelius,G. https://doi.org/10.1007/BF00408733
  18. Just. Liebigs Ann. Chem. Ambruticin VS: new members of the antifungal ambruticin family rom Sorangium cellulosum Hofle, G.;H. Steinmetz;K. Gerth;H. Reichenbach.
  19. Proc. Natl. Acad. Sci. v.87 Two independent frtrons with highly diverse reverse trancriptases in Myxococcus xanthus Inouye, S.;P.J. Herzer;M. Inouye. https://doi.org/10.1073/pnas.87.3.942
  20. J. Antibiot v.48 The tartrolos, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum Irschik,H.;D.Schummer;K.Gerth;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.48.26
  21. Arch. Microbiol. v.142 An unusual pattern of carbohydrate utilization in Corallococus coralloides Ccc127 Irschik,H.;H. Reichenbach. https://doi.org/10.1007/BF00409234
  22. J. Antibiot. v.48 The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria Irschik, H.;H. Augustiniak;K. Gerth;G. Hofle;H. Reichenbach. https://doi.org/10.7164/antibiotics.48.787
  23. J. Antibiot v.36 The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales) Irschik,H.;K.Gerth;G.Hofle;W.Kohl;H.Reichenbach https://doi.org/10.7164/antibiotics.36.1651
  24. J. Antibiot v.36 The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). 1. Cultivation, isolation,and some chemical and biologicalproperties Irschik,H.;K.Gerth;T.Kemmer;H.Steinmetz;H.Reichenbach https://doi.org/10.7164/antibiotics.36.6
  25. J. Antibiot v.38 The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria Irschik,H.;R.Jansen;G.Hofle;K.Gerth;H.Reichenbach https://doi.org/10.7164/antibiotics.38.145
  26. J. Antibiot. v.40 The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerae isolated from myxobacteria Irschik, H;R. Jansen;K. Gerth;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.40.7
  27. J.Antibiot v.48 Disorazol A, an eficient inhibitor of eukaryotic organisms isolated from myxobacteria Irschik,H.;R.Jansen;K.Gerth;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.48.31
  28. J. Antibiot. v.48 Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria Irschik, H.;R. Jansen;K. Gerth;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.48.962
  29. J. Antibiot. v.48 Sorangiolid A, a new antibiotic isolated from the myxobacterium Sorangium cellulosum So ce 12 Irschik, H.;R. Jansen;K. Gerth;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.48.886
  30. J. Antibiot v.41 Saframycin Mx1, a new natural saframycin isolated from a myxobacterium Irschik,H.;W.Trowitzsch-Kienast;K.Gerth;G.Hofle;H.Reichenbach
  31. Eur. J. Org. Chem. The crocacins, novel antifungal and cytotoxic antibiotics from Chondromyces crocatus and Chondromyces pediculatus (myxobacteria):isolation and structure elucidation Jansen,R.;P.Washausen;B.Kunze;H.Reichenbach;G.Hofle
  32. J. Antibiot v.44 Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells Kim,Y.J.;K.Furihata;S.Yamanaka;R.Fudo;H.Seto https://doi.org/10.7164/antibiotics.44.553
  33. J. Antibiot v.40 The aurachins, new quinoline antibiotics from myxobacteria:production, physico-chemical and biological proerties Kunze,B.;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.40.258
  34. J. Antibiot. v.35 Isolation and identifacation of althiomycin from Cystobacter fuscus (myxobacterales) Kunze, B.;H. Reichenbach;H. Augustiniak;G. Hofle. https://doi.org/10.7164/antibiotics.35.635
  35. J. Antibiot v.42 Myxochelin A. a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation,physico-chemical and biological properties Kunze,B.;N.Bedorf;W.Kohl;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.42.14
  36. J. Antibiot. v.48 Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria) Kunze, B.;R. Jansen;F. Sasse;G. Hofle;H. Reichenbach. https://doi.org/10.7164/antibiotics.48.1262
  37. J. Antibiot v.51 Apicularens A and B, new cytostatic macrolies from Chodromyces species (myxobacterales). production, physico-chemical and biological properties Kunze,B.;R.Jansen;F.Sasse;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.51.1075
  38. J. Antibiot v.47 Crocacin, a new electron tansport inhibitor from Chondromyces crocatus (myxobacterales). Production, isolation, physico-chemical and biological properties Kunze,B.;R.Jansen;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.47.881
  39. J. Antibiot. v.45 Phenoxan, a new oxazole-pyrone from myxobacteria: production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain Kunze, B.;R. Jansen;L. Pridzun;E. Jurkiewicz;G. Hunsmann;G. Hofle;H. Richenbach. https://doi.org/10.7164/antibiotics.45.1549
  40. J. Antibiot. v.37 Stigmatellin, a new antibiotic from Stigmatella aurantiaca(Myxobacterales). I. Production, physico-chemical and biological properties Kunze, B.;T. Kemmer;G. Hofle;H. Reichenbach. https://doi.org/10.7164/antibiotics.37.454
  41. J. Antibiot v.38 Production, isolation,physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales) Kunze,B.;W.Kohl;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.38.1649
  42. J. Antibiot. v.45 Nannochelins A, B and C, new ironchelating compounds from Nannocystis exedens (myxobacteria). Production, isolation, physico-chemical and biological properites Kunze, B.;W. Trowitzsch-Kienast;G. Hofle;H. Reichenbach. https://doi.org/10.7164/antibiotics.45.147
  43. J. Microbiol. Biotechnol v.12 Apicularen A, a macrolide from Chondromyces sp., inhibits growth factor induced in vitro angiogenesis Kwon,H.J.;D.H.Kim;J.S.Shim;J.W.Ahn
  44. J. Bacteriol. v.126 Ultrastructure of Polyangium cellulosum Lampky, J. R.
  45. J. Bacteriol. v.173 Survey of multicopy single-stranded DNAs and reverse transcriptase gene among natural isolates of Myxococcus xanthus Lampson B. C.;M. Inouye;S. Inouye.
  46. J. Nat. Prod. v.58 Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins Li,E.;A.M.Clark;D.P.Rotella;C.D.Hufford https://doi.org/10.1021/np50115a009
  47. Arch. Microbiol135 v.135 A phylogenetic analysis of the myxobacteria Myxococcus fulavus, Stigmatella aurantic, Cystobacter fuscus, Sorangium cellulosum and Namocystis exedens Ludwig,W.;K.H.Schleifer;H.Reichenbach;E.Stackebrandt https://doi.org/10.1007/BF00419483
  48. J. Gen. Microbiol. v.135 Ultrastructural details of the apparatus of gliding mobility of Myxococcus fulvus(Myxobacterales) Lunsdorg, H.;H. Reichenbach.
  49. Can, J. Microbiol v.21 Ultrastructural studies of Chondromyces crocatus vegetative cells MacRae,T.H.;H.D.McCurdy https://doi.org/10.1139/m75-264
  50. J. Gen. Microbiol. v.134 An extracellular blood-anticoagulant glycopeptide produced exclusively during vegetative growth by Myxococcus xanthus and other myxobacteria is not co-regulated with other extracellular macromolecules Masson,P.J.;J.F. Guespin-Michel.
  51. J. Bacteriol v.1362 Restriction endonucleases: general survey procedure and survey of gliding bacteria Mayer,H.;H.Reichenbach
  52. J. Antibiot. v.51 Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus Ojika, M.;Y. Suzuki;A. Tsukamoto;Y. Sakagami;R. Fudou;T. Yoshimura;S. Yamanaka https://doi.org/10.7164/antibiotics.51.275
  53. J. Antibiot v.41 Glidobactims A,B and C, new antitumor antibiotics, I. Production, isolation, chemical properties and biological activity Oka,M.;Y.Nishiyama;S.Ohta;H.Kamei;M.Konishi;T.Miyaki;T.Oki;H.Kawaguchi https://doi.org/10.7164/antibiotics.41.1331
  54. J. Bacteriol. v.174 Proudction of an extracellular milk-clotting activity during development in Myxococcus xanthus Petit, F.;J. F. Guespin-Michel.
  55. Myxobacteria The Encyclopedia of Bioprocess Technology : Fermentation, Biocatalysis, and Bioseperation Reichenbach, H.;M. C. Flickinger(ed.);S. W. Derw(ed.)
  56. J. Ind. Microbiol. Biotechnol v.27 Myxobacteria, a producers of novel bioactive substances Reichenbach,H. https://doi.org/10.1038/sj.jim.7000025
  57. The Prokaryotes v.4 The myxobacteria Reichenbach, H.;Dworkin, M.;K. P. Starr(ed.);H. Stolp(ed.);H. G. Truper(ed.);A. Belows(ed.);H. E. Schlegel(ed.)
  58. Biotech. Adv. v.11 Biologically active secondary metabolites from myxobacteria Reichenbach,H.;G.Hofle https://doi.org/10.1016/0734-9750(93)90042-L
  59. Myxobacteria Ⅱ, Am. Soc. Production of bioactive secondary metabolites Reichenbach, H.;G. Hofle;M. Dworkin(ed.);D. Kaiser(ed.)
  60. J. Gen. Microbiol v.58 Studies on Stigmatella aurantiaca (Myxobacterales) Reichenbach,H.;M.Dworkin https://doi.org/10.1099/00221287-58-1-3
  61. Drug Discovery from Nature Myxobacteria as a producers of secondary metabolites Reichebach. H.;G. Hofle.;S. Grabley(ed.);R. Thiericke(ed.)
  62. J. Antibiot v.30 Ambruticin (W7783), a new antifungal antibjotic Ringel,S.M.;R.C.Greenough;S.Roemer;D.Connor;A.L.Gutt;.B.Blair;G.Kanter;M.von Strandmann https://doi.org/10.7164/antibiotics.30.371
  63. J. Antibiot v.52 Melithizols, new methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties Sasse;F.B.Bohlendorf;M.Hermann;B.Kunze;E.Forche;H.Steinmetz;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.52.721
  64. J. Natl. Cand. Inst. v.90 The chondramides : cytostatic agent from myxobacteria actiong on the actin cytoskeleton Sass, F.;B. Kunze;T. M. A. Groneworld;H. Reichenbach https://doi.org/10.1093/jnci/90.20.1559
  65. J. Antibiot. v.46 Rhizopodin, a new compound from Myxococcus stipitatus(myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physicochemical and biological properties Sasse, F.;H. Steinmetz;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.46.741
  66. J. Antibiot v.48 Gephyronic acid, a novel inhibitor of eukaryotic protein synthesis from Archangium gephyra (myxobacteria). Production, isolation, physico-chemical and biologial properties, and mechanism of action Sasse,F.;H.Steinmetz;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.48.21
  67. J Antibiot. v.53 Tubulysins, new cytostaticpeptides from myxobacteria acting on microtubuli. Production, isolation,physicochemical and biological properties Sasse,F.;H. Steinmetz;J. Heil;G. Hofle;H. Reichenbach https://doi.org/10.7164/antibiotics.53.879
  68. J. Antibiot v.55 Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties Sasse,F.;H.Steinmetz;T.Schupp;F.Petersen;K.Memmert;H.Hofmann;C.Heusser;V.Brinkmann;P.von Matt;G.Hofle;H.Reichenbach https://doi.org/10.7164/antibiotics.55.543
  69. Proc. Natl. Acad. Sci. USA. v.89 A Phylogenetic analysis of the myxobacteria: basis for the classification Shimekets,L.;C. R. Woese.
  70. J. Gen. Microbiol v.1 Myxobacteria in soils and composts; their distribution, number and lytic acition on bacteria Singh,B.N. https://doi.org/10.2323/jgam.1.1
  71. Tetrahedron. v.54 Cystothiazoles C-f, new new bithiazoletype antibiotics from the myxobacterium Cystobacter fuscus Suzuki, Y.;M. Ojika;Y. Sakagami;R. Fudou;S. Yamanaka https://doi.org/10.1016/S0040-4020(98)00694-2
  72. J. Antibiot v.41 Novel macrocyclic antibiotics: megovalicins A, B, C.D, G and H. Ⅱ. Isolation and chemical structures of megovalicins Takayama,S.;S.Yamanaka;S.Miyashiro;Y.Yokokawa;H.Shibai https://doi.org/10.7164/antibiotics.41.439
  73. Just. Liebigs Ann. Chem. Phenalamid, neue HIV-1 inibitoen aus Myxococcus stipitatus Mx s40 Trowitz-Kienast, W.;E.Forche;V.Wray;E.Jurkiewicz;G.Hunsmann;G.Hofle
  74. Just. Liebigs Ann. Chem. Thiangazol, a novel inhibitory HIV-1 infection in cell cultures from Polyangium sp. Trowitz-Kienast, W.;E.Forche;V.Wray;E.Jurkiewicz;G.Hunsmann;G.Hofle
  75. Science v.277 Crystal structure of the cytochrome bc1-comples from bovine heart mitochondria Xia,D.;C.A.Yu;H.Kim;J.Z.Xia;A.M.Kachurin;L.Zhang;L.Yu;J.Deisenhofer https://doi.org/10.1126/science.277.5322.60
  76. J. Bacteriol v.174 identification of a putative eukaryotic-like protein kinase familyin the developmental bacterium Myxococcus xanthus Zhang,W.;J.Munoz-Dorado;M.Inouye;S.Inouye
  77. J. Bacteriol. v.174 Identification of a putative eukaryotic-like protein kinase family in the developmental bacterium Myxococcus xanthus Zhang, W.;J. Munoz-Dorado;M. Inouye;S. Inouye.